LEADER 02326nam  2200481   450 
001 9910317569403321
005 20221017112909.0
010   $a953-51-4268-2
035   $a(CKB)4970000000098390
035   $a(NjHacI)994970000000098390
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/57739
035   $a(MiAaPQ)EBC30390249
035   $a(Au-PeEL)EBL30390249
035   $a(EXLCZ)994970000000098390
100   $a20221017d2012      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aRecent Advances in Novel Drug Carrier Systems /$fedited by Ali Demir Sezer
205   $a1st ed.
210   $cIntechOpen$d2012
210  1$aRijeka, Croatia :$cIntechOpen,$d2012.
215   $a1 online resource  (x, 514 pages) $cillustrations
311   $a953-51-0810-7 
320   $aIncludes bibliographical references.
330   $aThis contribution book collects reviews and original articles from eminent experts working in the interdisciplinary arena of novel drug delivery systems and their uses. From their direct and recent experience, the readers can achieve a wide vision on the new and ongoing potentialities of different drug delivery systems. Since the advent of analytical techniques and capabilities to measure particle sizes in nanometer ranges, there has been tremendous interest in the use of nanoparticles for more efficient methods of drug delivery. On the other hand, this reference discusses advances in the design, optimization, and adaptation of gene delivery systems for the treatment of cancer, cardiovascular, pulmonary, genetic, and infectious diseases, and considers assessment and review procedures involved in the development of gene-based pharmaceuticals.
606   $aBiodegradation$vCongresses
610   $aToxicology and Pharmaceutical Science
610   $aPharmaceutical Drug
610   $aPharmacology
610   $aHealth Sciences
615  0$aBiodegradation
676   $a620.1
700   $aAli Demir Sezer$4auth$01366149
702   $aSezer$b Ali Demir
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910317569403321
996   $aRecent Advances in Novel Drug Carrier Systems$93389272
997   $aUNINA